CRANBURY, N.J., Jan. 23, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today announced the promotion of Bradley L. Campbell to the new position of Chief Business Officer.
